Skip to main content
. 2017 Jan 13;96(2):e5881. doi: 10.1097/MD.0000000000005881

Figure 2.

Figure 2

Participant flow of HIV-exposed and HIV-unexposed children vaccinated with 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine. ATP = according-to-protocol; N  = number of children; n = number with the characteristic; HEU = HIV-exposed-uninfected; HIV+ = HIV-infected; HUU = HIV-unexposed-uninfected; SAE = serious adverse event; TVC = total vaccinated cohort. ∗Only primary and first persistence analysis presented here. †Results presented elsewhere. Thirteen children with subject numbers were not vaccinated; they did not contribute to results.